Health Care & Life Sciences » Pharmaceuticals | Jiangsu Nhwa Pharmaceutical Co. Ltd.

Jiangsu Nhwa Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,217
2,479
2,741
2,984
3,355
3,810
Cost of Goods Sold (COGS) incl. D&A
1,340
1,514
1,618
1,637
1,777
1,716
Gross Income
877
965
1,123
1,347
1,578
2,093
SG&A Expense
659
686
806
994
1,167
1,498
EBIT
216
273
306
346
395
566
Non Operating Income/Expense
-
-
2
12
45
20
Interest Expense
17
20
18
12
10
14
Pretax Income
205
261
301
359
446
613
Income Tax
33
40
46
57
70
89
Equity in Affiliates
-
-
-
-
1
5
Consolidated Net Income
172
221
255
302
375
519
Net Income
176
223
258
310
395
525
Net Income After Extraordinaries
176
223
258
310
395
525
Net Income Available to Common
176
223
258
310
395
525
EPS (Basic)
0.18
0.23
0.26
0.31
0.39
0.52
Basic Shares Outstanding
981
981
995
1,009
1,009
1,009
EPS (Diluted)
0.18
0.23
0.26
0.31
0.39
0.52
Diluted Shares Outstanding
981
981
995
1,009
1,009
1,016
EBITDA
253
317
356
394
455
646
Other Operating Expense
2
6
11
7
17
29
Non-Operating Interest Income
5
7
6
14
16
30
Minority Interest Expense
4
2
3
8
19
6

About Jiangsu Nhwa Pharmaceutical Co.

View Profile
Address
En Hua Building
Xuzhou Jiangsu 221009
China
Employees -
Website http://www.nhwa-group.com
Updated 07/08/2019
Jiangsu Nhwa Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. Its focuses on central nervous system products. The company produces anesthesia, nervous system disease treatments, and nerve medicine raw materials.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.